These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11743358)
21. Growth and chemotherapy of a human germ-cell tumour line (GCT 27). Schlappack OK; Bush C; Delic JI; Steel GG Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535 [No Abstract] [Full Text] [Related]
22. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
23. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy. Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063 [TBL] [Abstract][Full Text] [Related]
24. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials. Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861 [TBL] [Abstract][Full Text] [Related]
25. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours. Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306 [TBL] [Abstract][Full Text] [Related]
27. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery. Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156 [TBL] [Abstract][Full Text] [Related]
28. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP; J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419 [TBL] [Abstract][Full Text] [Related]
29. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy. Gilbert DC; Norman AR; Nicholl J; Dearnaley DP; Horwich A; Huddart RA BJU Int; 2006 Jul; 98(1):67-9. PubMed ID: 16831145 [TBL] [Abstract][Full Text] [Related]
30. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ; J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806 [TBL] [Abstract][Full Text] [Related]
31. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659 [TBL] [Abstract][Full Text] [Related]
32. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ; J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336 [TBL] [Abstract][Full Text] [Related]
33. Management of good risk germ-cell tumours. Troost MM; Sternberg CN; de Wit R BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer. Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L Oncology; 2009; 77(1):33-9. PubMed ID: 19440001 [TBL] [Abstract][Full Text] [Related]
35. Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer. Böhlen D; Burkhard FC; Mills R; Sonntag RW; Studer UE J Urol; 2001 Feb; 165(2):441-4. PubMed ID: 11176393 [TBL] [Abstract][Full Text] [Related]
36. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
37. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B; Bode U; von Schweinitz D Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report. Azak A; Oksüzoğlu B; Deren T; Oneç BM; Zengin N Anticancer Drugs; 2008 Jan; 19(1):97-8. PubMed ID: 18043135 [TBL] [Abstract][Full Text] [Related]
39. [A case of advanced seminoma treated effectively with single agent carboplatin therapy]. Fukuzawa S; Yu A; Hashimura T; Oishi K; Yoshida O; Kuo SY Hinyokika Kiyo; 1992 Feb; 38(2):227-31. PubMed ID: 1561962 [TBL] [Abstract][Full Text] [Related]
40. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]